When PIC receptors are blocked in the dl-PAG, the abnormal descending pain pathways are largely restored because we have observed that chronic infusion of PIC antagonists lessened amplified pain responses in PD animals accompanied with increasing GABA levels in the PAG. Here, SLC25A3 is linked to Parkinson disease.